I'm not sure if the ease of distribution is enough of a differentiator imo. TLX gozellix kit appears to have a good shelf life which nullifies this. Efficacy in the guise of sensitivity for a diagnostic will be the main attractor for clinicians wanting to use cu6, if cu64 ends up with a much higher sensitivity.
- Forums
- ASX - By Stock
- Ann: First patient imaged in Phase III AMPLIFY trial
CU6
clarity pharmaceuticals ltd
Add to My Watchlist
3.36%
!
$2.31

I'm not sure if the ease of distribution is enough of a...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.31 |
Change
0.075(3.36%) |
Mkt cap ! $748.7M |
Open | High | Low | Value | Volume |
$2.30 | $2.37 | $2.21 | $4.694M | 2.040M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 2702 | $2.30 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.31 | 7832 | 19 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 2702 | 2.300 |
11 | 16435 | 2.290 |
11 | 34784 | 2.280 |
10 | 77321 | 2.270 |
7 | 20684 | 2.260 |
Price($) | Vol. | No. |
---|---|---|
2.310 | 7832 | 19 |
2.320 | 27107 | 23 |
2.330 | 20811 | 16 |
2.340 | 12913 | 15 |
2.350 | 17846 | 6 |
Last trade - 13.25pm 17/06/2025 (20 minute delay) ? |
Featured News
CU6 (ASX) Chart |
The Watchlist
RC1
REDCASTLE RESOURCES LIMITED
Ronald Miller, Non-Executive Director
Ronald Miller
Non-Executive Director
SPONSORED BY The Market Online